Conference
Quantitative Benefit-Risk Assessment of Rivaroxaban for the Prevention of Venous Thromboembolism.
Authors
Levitan B; Yuan Z; Turpie AGG; Friedman RJ; Homering M; Berlin JA; Berkowitz SD; DiBattiste PM
Volume
114
Pagination
pp. 75-76
Publisher
AMER SOC HEMATOLOGY
Publication Date
November 20, 2009
Name of conference
51st Annual Meeting of the American-Society-of-Hematology
Conference place
New Orleans, LA
Conference start date
December 5, 2009
Conference end date
December 8, 2009
Conference proceedings
BLOOD
Issue
22
ISSN
0006-4971